Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab versus azathioprine maintenance therapy in ANCA-associated vasculitis
2008-002846-51Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) comparing Rituximab maintenance with Azathioprine maintenance (2 arms). Started Dec 2009; status: active.
02
Drugs
rituximabazathioprine
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on 2008-002846-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002846-51.